Loss of Cannabinoid CB1 Receptors in the Basal Ganglia in the Late Akinetic Phase of Rats with Experimental Huntington's Disease

By Lastres-Becker Isabel   Gómez María   de Miguel Rosario   Ramos José A.   Fernández-Ruiz Javier  

Neurotoxicity Research, Vol. 4, Iss. 7-8, 2002-01 ,pp. : 601-608

Springer Publishing Company

Access to resources Recommend Favorite

Striatal Cannabinoid CB1 Receptor mRNA Expression Is Decreased in the Reserpine-Treated Rat Model of Parkinson's Disease

By Silverdale M.A.   McGuire S.   McInnes A.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 169, Iss. 2, 2001-06 ,pp. : 400-406

Elsevier

Access to resources Recommend Favorite

Neuronal degeneration in striatal transplants and Huntingtons disease: potential mechanisms and clinical implications

By Cicchetti Francesca  

Brain, Vol. 134, Iss. 3, 2011-03 ,pp. : 641-652

Oxford University Press

Access to resources Recommend Favorite

Striatal neural grafting improves cortical metabolism in Huntington’s disease patients

By Gaura Véronique  

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 65-72

Oxford University Press

Access to resources Recommend Favorite

Striatal allografts in patients with Huntingtons disease: impact of diminished astrocytes and vascularization on graft viability

By Cisbani Giulia  

Brain, Vol. 136, Iss. 2, 2013-02 ,pp. : 433-443

Oxford University Press

Access to resources Recommend Favorite